Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome.

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol (2011) 1.19

Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol (2012) 1.02

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol (2012) 1.02

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol (2015) 0.85

Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol (2012) 0.81

Chapter 4: Steroid-resistant nephrotic syndrome in children. Kidney Int Suppl (2011) (2012) 0.81

Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol (2012) 0.79

Paediatric use of mycophenolate mofetil. Br J Clin Pharmacol (2013) 0.77

Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. J Am Soc Nephrol (2017) 0.75

Nephrotic syndrome in childhood. Lancet (2003) 3.36

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr (1981) 3.01

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation (1995) 2.67

Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int (2002) 2.31

High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol (1999) 1.62

Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol (2003) 1.57

The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol (2002) 1.38

The use of mycophenolate mofetil in transplant recipients. Immunopharmacology (2000) 1.13

RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11

Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis (1994) 1.11

Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem (1995) 1.11

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatr Nephrol (2005) 1.08

Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol (2005) 0.99

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis (2003) 0.97

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant (2002) 0.92

Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study. Nephrol Dial Transplant (2007) 0.85

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol (2003) 0.84

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediatr Nephrol (2003) 0.82

Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Pediatr Int (2007) 0.82

Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis (2000) 0.82

Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study. Nephron Clin Pract (2009) 0.80

Enalapril and prednisone in children with nephrotic-range proteinuria. Pediatr Nephrol (2000) 0.77

Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity. Transpl Int (2000) 0.76

[Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study]. Nephrol Ther (2007) 0.75

Mycophenolate mofetil: a decade of clinical experience. Transplantation (2005) 0.75

Antibiotic resistance patterns of pediatric community-acquired urinary infections. Braz J Infect Dis (2008) 0.95

Guidelines to diagnosis and monitoring of Fabry disease and review of treatment experiences. J Pediatr (2009) 0.87

Prognosis for children with acute kidney injury in the intensive care unit. Pediatr Nephrol (2008) 0.84

High rate of Staphylococcus aureus oropharyngeal colonization in children. J Infect (2011) 0.83

E. coli virulence factors in children with neurogenic bladder associated with bacteriuria. Pediatr Nephrol (2005) 0.82

[Reproducibility of the classification of ocular ferning patterns in Sjogren's syndrome patients]. Arq Bras Oftalmol (2008) 0.79

Antipyretic effect of ibuprofen and dipyrone in febrile children. J Pediatr (Rio J) (2011) 0.75

Prognostic assessment of polymorphisms of the MDR-1 and GSTP1 genes in patients with stage II and III breast cancer submitted to neoadjuvant chemotherapy. Breast J (2012) 0.75

Analysis of transplant rejection in rabbits aponeurosis. Einstein (Sao Paulo) (2013) 0.75

[Periorbital liposarcoma in pediatric patient: a case report]. Arq Bras Oftalmol (2013) 0.75